We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Chest Computed Tomography (CT) Screening Study With Antibody Testing

This study has been withdrawn prior to enrollment.
(Due to lack of funding)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01203579
First Posted: September 16, 2010
Last Update Posted: June 21, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Mayo Clinic
September 15, 2010
September 16, 2010
June 21, 2012
September 2011
September 2011   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01203579 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Chest Computed Tomography (CT) Screening Study With Antibody Testing
Different Strategies Using Autoantibodies and/or CT in the Detection of Lung Cancer
The purpose of this study is to assess the value of EarlyCDT-Lung test and CT scan both in lung cancer detection and potential health economic outcomes.
EarlyCDT-Lung test and CT scan both for lung cancer detection and potential economic outcomes.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Current or Former Smokers with >20 pack year history and or family history of lung cancer. Ages 50-75 years old
Lung Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
September 2011
September 2011   (Final data collection date for primary outcome measure)
  • Persons 50-75
  • Asymptomatic for lung cancer
  • Current or former (stopped smoking less than 10 years ago) cigarette smokers
  • History of cigarette smoking of at least 20 pack years
  • History of cigarette smoking with a family history of lung cancer which gives an individual a personal risk similar to a smoking history of 20 pk/years (i.e. 1% at 5 years).
  • Mentally competent individuals to sign an informed consent.
  • Healthy enough to undergo pulmonary resection or stereotactic body radiotherapy.
  • A fully informed signed consent form must have been obtained.
Sexes Eligible for Study: All
50 Years to 75 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01203579
10-003048
No
Not Provided
Not Provided
David Midthun, MD, Mayo Clinic
Mayo Clinic
Not Provided
Principal Investigator: David Midthun, MD Mayo Clinic
Mayo Clinic
June 2012